Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | VIM |
| Upstream (Parents) |
|---|
| (<<) AKAP12 → VIM |
| (<<) CLEC2B → VIM |
| (<<) HSPA8 → VIM |
| (<<) IGFBP7 → VIM |
| (<<) MYL9 → VIM |
| (<<) PGK1 → VIM |
| (<<) RHOA → VIM |
| (<<) SEPW1 → VIM |
| (<<) SET → VIM |
| Downstream (Children) |
|---|
| VIM → ADAM12 (>>) |
| VIM → CAV1 (>>) |
| VIM → CD4 (>>) |
| VIM → CDH11 (>>) |
| VIM → CDKN1A (>>) |
| VIM → CEBPA (>>) |
| VIM → CHI3L1 (>>) |
| VIM → CHST12 (>>) |
| VIM → CHST3 (>>) |
| VIM → CORO1A (>>) |
| VIM → CTGF (>>) |
| VIM → CYP4F2 (>>) |
| VIM → DHCR7 (>>) |
| VIM → DPH2 (>>) |
| VIM → DUSP6 (>>) |
| VIM → EFEMP2 (>>) |
| VIM → EGFR (>>) |
| VIM → FAS (>>) |
| VIM → G0S2 (>>) |
| VIM → GPNMB (>>) |
| VIM → GRN (>>) |
| VIM → GYPC (>>) |
| VIM → HDAC6 (>>) |
| VIM → HOPX (>>) |
| VIM → ID1 (>>) |
| VIM → IGFBP6 (>>) |
| VIM → ISLR (>>) |
| VIM → ITGA5 (>>) |
| VIM → KLF11 (>>) |
| VIM → KLHL7 (>>) |
| VIM → LCP1 (>>) |
| VIM → MMP2 (>>) |
| VIM → MMP3 (>>) |
| VIM → MSN (>>) |
| VIM → MT1F (>>) |
| VIM → MXRA8 (>>) |
| VIM → NBL1 (>>) |
| VIM → NFATC3 (>>) |
| VIM → NNMT (>>) |
| VIM → NRN1 (>>) |
| VIM → ORC6L (>>) |
| VIM → PODXL (>>) |
| VIM → PRKX (>>) |
| VIM → PTRF (>>) |
| VIM → RAB5C (>>) |
| VIM → RASA1 (>>) |
| VIM → SPR (>>) |
| VIM → SULF1 (>>) |
| VIM → SYK (>>) |
| VIM → SYNPO (>>) |
| VIM → TCF4 (>>) |
| VIM → TPM4 (>>) |
| VIM → WNT3 (>>) |
